Treatment of Hyperkalemia in Heart Failure
Sign Up to like & getrecommendations! Published in 2017 at "Current Heart Failure Reports"
DOI: 10.1007/s11897-017-0341-0
Abstract: Purpose of ReviewThe aim of this paper is to discuss strategies for prevention and management of hyperkalemia in patients with heart failure, including the role of novel therapies.Recent FindingsRenin-angiotensin-aldosterone system (RAAS) antagonists, including angiotensin-converting enzyme… read more here.
Keywords: hyperkalemia; risk hyperkalemia; heart failure;
Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehac544.984
Abstract: Occurrence of hyperkalemia has been a great limitation in the full implementation of a guideline-directed medical therapy especially in patients with heart failure. Recent developments have exhibited the positive role of SGLT2 inhibitors, not only… read more here.
Keywords: receptor antagonist; hyperkalemia patients; hyperkalemia; risk hyperkalemia ... See more keywords
Comparative risk of new‐onset hyperkalemia for antihypertensive drugs in patients with diabetic nephropathy: A Bayesian network meta‐analysis
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.13940
Abstract: Several randomised controlled trials (RCTs) have evaluated the risk of hyperkalemia of antihypertensive drugs on diabetic nephropathy, yet the results are conflicting. We searched MEDLINE, Embase, The Cochrane Library, and Web of Science for RCTs… read more here.
Keywords: risk; group; hyperkalemia; diabetic nephropathy ... See more keywords